SHARE CAPITAL (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 29, 2018 |
Jul. 20, 2018 |
Feb. 26, 2015 |
Feb. 13, 2015 |
Mar. 31, 2018 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Mar. 31, 2018 |
Sep. 30, 2018 |
Jun. 12, 2018 |
Nov. 06, 2017 |
Mar. 31, 2017 |
Dec. 31, 2014 |
|
Loss on Mark to Market Reevaluation | $ (2,048,697) | $ 0 | |||||||||||
Stock Issued During Period, Shares, Exchangeable Shares Excercised | 21,572 | 24,250 | |||||||||||
Common Stock, Shares Authorized | 250,000,000 | 500,000,000 | 250,000,000 | 500,000,000 | 500,000,000 | 250,000,000 | 150,000,000 | 200,000,000 | |||||
Stock Issued During Period, Value, Conversion of Convertible Securities | $ 4,732,853 | $ 9,180,785 | $ 2,470,622 | ||||||||||
Adjustments to Additional Paid in Capital, Stock Option and Warrant Reclassification | $ (2,845,557) | $ 1,173,534 | |||||||||||
Preferred Stock, Voting Rights | the Company issued one share of the Special Voting Preferred Stock, par value $0.001 per share | ||||||||||||
Stockholders' Equity, Reverse Stock Split | the Company completed a reverse stock split and thereafter Bionik’s common stock began trading on the OTCQB market on a one-for-one hundred and fifty (1:150) split-adjusted basis. | the Company implemented a 1-for-0.831105 reverse stock split of the common stock, which had previously been approved on September 24, 2014. | |||||||||||
Common Shares [Member] | |||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 947,034 | ||||||||||||
Convertible Debt [Member] | |||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | $ 683,395 | ||||||||||||
Convertible Debt [Member] | Common Shares [Member] | |||||||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities | 263,639 |